The New York outpatient clinic where the late Joan Rivers suffered cardiac arrest did not follow all the standard protocols during the throat procedures it conducted on the comedian, according to a government agency report.

Rivers died on September 4 at the age of 81 in a New York hospital a week after her heart stopped during the outpatient procedure at the Yorkville Endoscopy centre on Manhattan’s Upper East Side.

The Centres for Medicare & Medicare Services (CMS), the agency that released the report, said there was no record that staff at the centre weighed the comedian before administering the sedative Propofol on August 28 and there were inconsistencies recorded in the dosage of the drug.

It also said there were no records of medical consent for all the procedures performed. The report added that a doctor who was in the operating room was there without authorisation and said physicians also failed to detect her deteriorating vital signs during the procedures.

Daughter outraged by misconduct and mismanagement that occurred

Melissa Rivers, the comedian’s only child, said in a statement that she is “outraged by the misconduct and mismanagement” that occurred and will ensure it does not happen again with any other patient.

Her lawyers are investigating the circumstances surrounding her mother’s death.

The CMS released the report following an investigation by the New York State Department of Health, which questioned doctors and staff and examined records at the clinic.

The New York Chief Medical Examiner’s Office said Rivers died of a predictable complication during a medical procedure and lack of oxygen to the brain.

The CMS said another unannounced survey will be conducted at the clinic and if corrections are made and it is in substantial compliance it will not face termination of federal Medicare and Medicaid funding.

Sign up to our free newsletters

Get the best updates straight to your inbox:
Please select at least one mailing list.

You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.